US EditionQuince appoints Dr. Hassan Abolhassani to SAB - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Quince appoints Dr. Hassan Abolhassani to SAB - BioTuesdays
Quince Therapeutics (NASDAQ: QNCX) has announced the appointment of leading immunologist, Hassan Abolhassani, MD, PhD, to its scientific advisory board (SAB). Dr. Abolhassani currently serves as assistant professor of clinical immunology and research specialists in the department of medical biochemistry and biophysics at the Karolinska Institutet in Stockholm, Sweden. In a statement, Dr. Mauro Magnani, PhD, chair of Quince’s SAB, commented, “Qui…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
